American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

Journal of Oncology Practice

Volumn 6, Issue 5, 2010, Pages 243-246

  Burstein, Harold J ^a   Griggs, Jennifer J ^a   Prestrud, Ann A ^a   Temin, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; TAMOXIFEN;

ADJUVANT THERAPY; BREAST CANCER; CANCER THERAPY; CLINICAL PRACTICE; HORMONAL THERAPY; HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; SHORT SURVEY;

EID: 78751485465     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.000082     Document Type: Short Survey

References (1)

1. Burstein HJ, Prestrud AA, Seidenfeld J, et al: American Society of Clinical Oncology clinical practice guidelines: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28:3784-3796, 2010